A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy.

ABSTRACT:

SUBMITTER: Vo MC 

PROVIDER: S-EPMC8166870 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature